Donna Mojdami

Statistics

Publications

Citations

152

H-Index

Active since

2002

Affiliations

Eli Lilly (United States)(Current)

Johns Hopkins Medicine

Johns Hopkins University

Donna Mojdami is an author at Eli Lilly (United States) specializing in diabetes mellitus, pharmacotherapy, and phosphatidylinositol 3-kinase akt signaling.

Publications per year

2002–2025

Publications

Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the <scp>SURMOUNT</scp> ‐1 study

Kimberly A. Gudzune, Adam Stefański, Dachuang Cao et al. · Diabetes Obesity and Metabolism · 2024 · 42 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Nutrition +16

FcγR-Mediated Phagocytosis Stimulates Localized Pinocytosis in Human Neutrophils

Roberto J. Botelho, Hans Tapper, Wendy Furuya et al. · The Journal of Immunology · 2002 · 40 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Conversations and Reactions Around Severe Hypoglycemia Study: Results of Hypoglycemia Experiences in Canadian Adults With Insulin-Treated Diabetes and Their Caregivers

Donna Mojdami, Beth Mitchell, Erik Spaepen et al. · Canadian Journal of Diabetes · 2020 · 19 citations · Full text

Medicine, Internal Medicine, Communication In Serious Illness +7

Real‐world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database

Emily R. Hankosky, Chanadda Chinthammit, Alexandra Meeks et al. · Diabetes Obesity and Metabolism · 2025 · 15 citations · Full text

Pharmacy, Pharmacotherapy, Pharmacy Practice +15

Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the <scp>SURMOUNT</scp> program

Beverly G. Tchang, Andreea Ciudin Mihai, Adam Stefański et al. · Obesity · 2025 · 14 citations · Full text

Medicine, Endocrinology, Gynecology +17

1–5 of 7